Researchers Linked IDUA Gene to Inherited Blindness
A new study reveals that mutations in the IDUA gene can cause retinitis pigmentosa without metabolic symptoms.
Updated on Oct. 6, 2026 in Life Sciences
Live Poll
Should doctors perform broader genetic testing for patients experiencing unexplained vision loss?
Scientists have identified a link between inherited blindness and the IDUA gene, traditionally associated with mucopolysaccharidosis type I. The research demonstrates that certain mutations allow enough residual enzyme activity to avoid severe systemic health issues while still causing retinitis pigmentosa.
Why it matters
This discovery alters the diagnostic approach for patients with unexplained retinal disease by highlighting a gene previously linked to broader metabolic syndromes. It suggests that clinicians should broaden their genetic screenings for patients with similar vision-related conditions.
The study utilized a functional platform to measure enzyme activity levels across 14 individuals from 12 families. Researchers found that IDUA gene mutations allowed sufficient residual enzyme activity to prevent physical, heart, and skeletal symptoms.
The players
Greenwood Genetic Center
This is a non-profit organization that focuses on the clinical diagnosis and research of genetic disorders.
University of Manchester
This is a public research university that contributes to global academic studies in science and medicine.
The details
Researchers from over 20 institutions, including the Greenwood Genetic Center and the University of Manchester, utilized advanced genetic testing to confirm that participants carried mutations in both copies of the IDUA gene. This study challenges previous medical understandings by identifying retinitis pigmentosa as a standalone outcome of these specific mutations.
Timeline
October 6, 2026: The study was published and reviewed in The American Journal of Human Genetics.
The Big Picture
This discovery follows a pattern set by studies in The American Journal of Human Genetics that seek to refine the understanding of hereditary disease origins. It shifts the paradigm by proving that genes associated with severe metabolic syndromes can manifest as isolated conditions.
Patients with inherited retinal disease may benefit from updated genetic screening protocols that include the IDUA gene. This change could lead to more accurate diagnoses and prevent unnecessary testing for symptoms that are not present in these specific mutation cases.
The takeaway
Clinicians should incorporate the IDUA gene into testing panels for patients experiencing unexplained inherited vision loss. This finding serves as a reminder that complex genetic conditions can present with highly specific, localized symptoms.
Further reading
For more information on the latest breakthroughs in clinical genetics, explore the Life Sciences section.
More information
Read the complete peer reviewed study in AJHG00349-6) to learn more about the genetic findings.
Live Poll
Should doctors perform broader genetic testing for patients experiencing unexplained vision loss?
